Pharmacology of antiplatelet agents

Keyphrases

• Pharmacology 100%
• Antiplatelet Agents 100%
• Current Treatment 50%
• Attenuation 50%
• Acute Coronary Syndrome 50%
• Platelet Inhibition 50%
• Cyclooxygenase-1 (COX-1) 50%
• Coagulation 50%
• Anticoagulants 50%
• Clot 50%
• Treatment Strategy 50%
• Platelet Activation 50%
• Pharmacotherapy 50%
• Platelet Function 50%
• Percutaneous Coronary Intervention 50%
• Antiplatelet Therapy 50%
• Procoagulant Activity 50%
• Protease-activated Receptor 1 (PAR1) 50%
• Activity Inhibition 50%
• Thrombin Generation 50%
• P2Y12 Receptor 50%
• Complication Prevention 50%
• Glycoprotein IIb/IIIa Receptor 50%
• Synergetics 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Antithrombocytic Agent 100%
• Receptor 50%
• Thrombin 50%
• Pharmacotherapy 50%
• Acute Coronary Syndrome 50%
• Fibrinogen Receptor 50%
• Cyclooxygenase 1 50%
• Proteinase Activated Receptor 1 50%
• Anticoagulant Agent 50%
• Antiplatelet 50%
• Fibrinolytic Agent 50%
• Procoagulant 50%
• Purinergic P2Y12 Receptor 50%
• Enzymes 50%